The HCPLive asthma page is a comprehensive resource for clinical news and insights on asthmatic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for allergic and severe asthma, and more.
April 17th 2024
This analysis looked at the potential connection between SARS-CoV-2 test positivity and new asthma diagnoses.
COPD, Asthma May Increase Risk for Inflammatory Bowel Disease
Study results published in the European Respiratory Journal show that rates of inflammatory bowel disease (IBD) incidence have significantly increased in individuals with asthma or chronic obstructive pulmonary disease (COPD).
Looking at the Link Between Asthma and Cardiovascular Disease
Whether asthma contributes to cardiovascular disease or not is a matter for continued research and study. Whether there is a direct link or not there has been considerable proof that the numbers for both conditions are on the rise.
Looking at Advances in the Treatment of Occupational Asthma
For patients diagnosed with occupational asthma, sometimes taking a step as simple as leaving work can improve their condition. For others, finding relief may be a much more involved process that requires more comprehensive treatment.
Childhood Obesity and Risk of Allergy or Asthma
A recent study looked at the relationship between obesity and a child's risk of developing allergies or an asthmatic condition. Looking at what the authors perceived to be a growing trend of not only an increase in the number obese children but those suffering from new or worsening allergies the authors said they were looking for a link which could help treat the pediatric patients.
No Absence of Key Antiviral Mechanism in Asthmatics
October 1st 2014Because a key antiviral defense mechanism is present in asthmatics, another defect in their immune system must explain their difficulty combating respiratory viruses, according to researchers from Washington University in St. Louis.
Many Schools Not Prepared to Handle Emergencies Involving Children with Food Allergies and Asthma
New research from Northwestern University has found that schools are woefully unprepared to deal with anaphylaxis and other life-threatening emergencies stemming from student allergies.
Enterovirus D68 Not Life-Threatening
As Enterovirus D68 continues to spread across the US, the prognosis for children who are hospitalized with infections tends to be good. That applies to children with asthma, as well. "It's hard to say whether this virus is hitting kids with asthma harder than other viruses-but it is not causing as severe symptoms as other viruses out there, like adenovirus," said Christopher Carroll, MD, a pediatric intensivist and asthma specialist at Connecticut Children's Medical Center in Hartford, CT. "Even certain strains of rhinovirus are worse," Carroll said.
Delving Into Adherence With Multiple Sclerosis Therapies
September 16th 2014Adherence is defined as conforming to the recommendations made by the provider with respect to timing, dosage, and frequency of medication taking, and following these recommendations is important for patients with multiple sclerosis (MS) to fully benefit from disease-modifying therapies (DMTs).
AUGMENT Study Results Show Combination Therapy Superior to Monotherapy for COPD
May 20th 2014Treatment with a fixed-dose combination of aclidinium 400 µg and formoterol 12 µg significantly improved bronchodilation in patients with moderate to severe COPD compared with aclidinium or formoterol monotherapy alone.
Rosuvastatin Treatment Does Not Improve Lung Function in Patients with COPD
May 19th 2014Study results presented at the 2014 American Thoracic Society International Conference show that treatment with rosuvastatin reduces markers of inflammation in patients with COPD after 12 weeks, but is not associated with improvements in measures of lung function.
Simvastatin Does Not Affect Exacerbation Rates in High-Risk Patients with COPD
May 19th 2014Study results presented at the 2014 American Thoracic Society International Conference show that treatment with simvastatin did not decrease exacerbation rates or time to first exacerbation in patients with COPD.